Summary of Study ST003176
This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR001975. The data can be accessed directly via it's Project DOI: 10.21228/M8F723 This work is supported by NIH grant, U2C- DK119886.
See: https://www.metabolomicsworkbench.org/about/howtocite.php
This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.
Study ID | ST003176 |
Study Title | Chronic manganese exposure disrupts glutamatergic signaling and alters behavior in APP/PSEN1 mice. |
Study Type | untargeted metabolomics analysis |
Study Summary | Pathological changes in Alzheimer’s disease (AD) begin decades before cognitive symptoms appear. Chronic exposure to environmental neurotoxins like manganese (Mn) from sources such as air pollution and water can impact disease development across decades. Mn toxicity can lead to motor and neuropsychiatric symptoms resembling Parkinson's disease, attributed to its accumulation in globus pallidus. In contrast, the impact of chronic lower-level exposures on normal and neuropathological brain function is unknown. We tested whether 10 months of a high Mn diet (2400 ppm) could alter aspects of glutamate signaling in APP/PSEN1 mice to further exacerbate cognitive impairments compared to control fed animals (70 ppm). This study supports the potential role for chronic environmental exposures in the development of Alzheimer’s disease associated neuropathology. |
Institute | Vanderbilt University |
Department | Chemistry |
Laboratory | Center for Innovative Technology |
Last Name | CODREANU |
First Name | SIMONA |
Address | 1234 STEVENSON CENTER LANE |
SIMONA.CODREANU@VANDERBILT.EDU | |
Phone | 6158758422 |
Submit Date | 2024-04-18 |
Num Groups | 6 |
Total Subjects | 53 |
Num Males | 26 |
Num Females | 27 |
Study Comments | This study supports the potential role for chronic environmental exposures in the development of Alzheimer’s disease associated neuropathology. |
Raw Data Available | Yes |
Raw Data File Type(s) | raw(Thermo) |
Analysis Type Detail | LC-MS |
Release Date | 2024-10-18 |
Release Version | 1 |
Select appropriate tab below to view additional metadata details:
Project:
Project ID: | PR001975 |
Project DOI: | doi: 10.21228/M8F723 |
Project Title: | Chronic manganese exposure disrupts glutamatergic signaling and alters behavior in APP/PSEN1 mice. |
Project Type: | Untargeted Metabolomics analysis |
Project Summary: | Pathological changes in Alzheimer’s disease (AD) begin decades before cognitive symptoms appear. Chronic exposure to environmental neurotoxins like manganese (Mn) from sources such as air pollution and water can impact disease development across decades. Mn toxicity can lead to motor and neuropsychiatric symptoms resembling Parkinson's disease, attributed to its accumulation in globus pallidus. In contrast, the impact of chronic lower-level exposures on normal and neuropathological brain function is unknown. We tested whether 10 months of a high Mn diet (2400 ppm) could alter aspects of glutamate signaling in APP/PSEN1 mice to further exacerbate cognitive impairments compared to control fed animals (70 ppm). This study supports the potential role for chronic environmental exposures in the development of Alzheimer’s disease associated neuropathology. |
Institute: | Vanderbilt University |
Department: | Chemistry |
Laboratory: | Center for Innovative Technology |
Last Name: | CODREANU |
First Name: | SIMONA |
Address: | 1234 STEVENSON CENTER LANE |
Email: | SIMONA.CODREANU@VANDERBILT.EDU |
Phone: | 6158758422 |
Subject:
Subject ID: | SU003295 |
Subject Type: | Mammal |
Subject Species: | Mus musculus |
Taxonomy ID: | APP/PSEN1 mice were originally obtained from Jackson Laboratories (#034833) and bred with C57Bl/6J mice (#000664). |
Genotype Strain: | APP/PSEN1 and WT |
Age Or Age Range: | 12 months old |
Gender: | Male and female |
Animal Animal Supplier: | Jackson Laboratories |
Factors:
Subject type: Mammal; Subject species: Mus musculus (Factor headings shown in green)
mb_sample_id | local_sample_id | Sample source | Sex | Genotype | Mn Treatment |
---|---|---|---|---|---|
SA343211 | C2n | Brain-Cortex | Female | PS1 | High |
SA343212 | C3n | Brain-Cortex | Female | PS1 | High |
SA343213 | C4n | Brain-Cortex | Female | PS1 | High |
SA343214 | C2 | Brain-Cortex | Female | PS1 | High |
SA343215 | C1 | Brain-Cortex | Female | PS1 | High |
SA343216 | C1n | Brain-Cortex | Female | PS1 | High |
SA343217 | C3 | Brain-Cortex | Female | PS1 | High |
SA343218 | C4 | Brain-Cortex | Female | PS1 | High |
SA343219 | C8n | Brain-Cortex | Female | PS1 | Low |
SA343220 | C7n | Brain-Cortex | Female | PS1 | Low |
SA343221 | C6n | Brain-Cortex | Female | PS1 | Low |
SA343222 | C9n | Brain-Cortex | Female | PS1 | Low |
SA343223 | C10n | Brain-Cortex | Female | PS1 | Low |
SA343224 | C12n | Brain-Cortex | Female | PS1 | Low |
SA343225 | C11n | Brain-Cortex | Female | PS1 | Low |
SA343226 | C5n | Brain-Cortex | Female | PS1 | Low |
SA343227 | C9 | Brain-Cortex | Female | PS1 | Low |
SA343228 | C7 | Brain-Cortex | Female | PS1 | Low |
SA343229 | C12 | Brain-Cortex | Female | PS1 | Low |
SA343230 | C11 | Brain-Cortex | Female | PS1 | Low |
SA343231 | C10 | Brain-Cortex | Female | PS1 | Low |
SA343232 | C6 | Brain-Cortex | Female | PS1 | Low |
SA343233 | C8 | Brain-Cortex | Female | PS1 | Low |
SA343234 | C5 | Brain-Cortex | Female | PS1 | Low |
SA343235 | C13n | Brain-Cortex | Female | WT | High |
SA343236 | C14n | Brain-Cortex | Female | WT | High |
SA343237 | C19n | Brain-Cortex | Female | WT | High |
SA343238 | C19 | Brain-Cortex | Female | WT | High |
SA343239 | C15n | Brain-Cortex | Female | WT | High |
SA343240 | C18 | Brain-Cortex | Female | WT | High |
SA343241 | C17 | Brain-Cortex | Female | WT | High |
SA343242 | C16 | Brain-Cortex | Female | WT | High |
SA343243 | C14 | Brain-Cortex | Female | WT | High |
SA343244 | C13 | Brain-Cortex | Female | WT | High |
SA343245 | C16n | Brain-Cortex | Female | WT | High |
SA343246 | C17n | Brain-Cortex | Female | WT | High |
SA343247 | C18n | Brain-Cortex | Female | WT | High |
SA343248 | C15 | Brain-Cortex | Female | WT | High |
SA343249 | C24n | Brain-Cortex | Female | WT | Low |
SA343250 | C22n | Brain-Cortex | Female | WT | Low |
SA343251 | C25n | Brain-Cortex | Female | WT | Low |
SA343252 | C20n | Brain-Cortex | Female | WT | Low |
SA343253 | C21n | Brain-Cortex | Female | WT | Low |
SA343254 | C23n | Brain-Cortex | Female | WT | Low |
SA343255 | C26n | Brain-Cortex | Female | WT | Low |
SA343256 | C27 | Brain-Cortex | Female | WT | Low |
SA343257 | C25 | Brain-Cortex | Female | WT | Low |
SA343258 | C26 | Brain-Cortex | Female | WT | Low |
SA343259 | C23 | Brain-Cortex | Female | WT | Low |
SA343260 | C24 | Brain-Cortex | Female | WT | Low |
SA343261 | C22 | Brain-Cortex | Female | WT | Low |
SA343262 | C20 | Brain-Cortex | Female | WT | Low |
SA343263 | C27n | Brain-Cortex | Female | WT | Low |
SA343264 | C21 | Brain-Cortex | Female | WT | Low |
SA343265 | C32 | Brain-Cortex | Male | PS1 | High |
SA343266 | C30 | Brain-Cortex | Male | PS1 | High |
SA343267 | C31 | Brain-Cortex | Male | PS1 | High |
SA343268 | C28 | Brain-Cortex | Male | PS1 | High |
SA343269 | C29n | Brain-Cortex | Male | PS1 | High |
SA343270 | C28n | Brain-Cortex | Male | PS1 | High |
SA343271 | C32n | Brain-Cortex | Male | PS1 | High |
SA343272 | C29 | Brain-Cortex | Male | PS1 | High |
SA343273 | C30n | Brain-Cortex | Male | PS1 | High |
SA343274 | C31n | Brain-Cortex | Male | PS1 | High |
SA343275 | C35 | Brain-Cortex | Male | PS1 | Low |
SA343276 | C35n | Brain-Cortex | Male | PS1 | Low |
SA343277 | C36n | Brain-Cortex | Male | PS1 | Low |
SA343278 | C37n | Brain-Cortex | Male | PS1 | Low |
SA343279 | C34n | Brain-Cortex | Male | PS1 | Low |
SA343280 | C33n | Brain-Cortex | Male | PS1 | Low |
SA343281 | C34 | Brain-Cortex | Male | PS1 | Low |
SA343282 | C36 | Brain-Cortex | Male | PS1 | Low |
SA343283 | C37 | Brain-Cortex | Male | PS1 | Low |
SA343284 | C33 | Brain-Cortex | Male | PS1 | Low |
SA343285 | C43n | Brain-Cortex | Male | WT | High |
SA343286 | C44n | Brain-Cortex | Male | WT | High |
SA343287 | C45n | Brain-Cortex | Male | WT | High |
SA343288 | C53n | Brain-Cortex | Male | WT | High |
SA343289 | C42n | Brain-Cortex | Male | WT | High |
SA343290 | C41n | Brain-Cortex | Male | WT | High |
SA343291 | C39n | Brain-Cortex | Male | WT | High |
SA343292 | C40n | Brain-Cortex | Male | WT | High |
SA343293 | C38n | Brain-Cortex | Male | WT | High |
SA343294 | C53 | Brain-Cortex | Male | WT | High |
SA343295 | C43 | Brain-Cortex | Male | WT | High |
SA343296 | C44 | Brain-Cortex | Male | WT | High |
SA343297 | C41 | Brain-Cortex | Male | WT | High |
SA343298 | C40 | Brain-Cortex | Male | WT | High |
SA343299 | C38 | Brain-Cortex | Male | WT | High |
SA343300 | C39 | Brain-Cortex | Male | WT | High |
SA343301 | C45 | Brain-Cortex | Male | WT | High |
SA343302 | C42 | Brain-Cortex | Male | WT | High |
SA343303 | C51n | Brain-Cortex | Male | WT | Low |
SA343304 | C50n | Brain-Cortex | Male | WT | Low |
SA343305 | C52n | Brain-Cortex | Male | WT | Low |
SA343306 | C50 | Brain-Cortex | Male | WT | Low |
SA343307 | C51 | Brain-Cortex | Male | WT | Low |
SA343308 | C49n | Brain-Cortex | Male | WT | Low |
SA343309 | C48n | Brain-Cortex | Male | WT | Low |
SA343310 | C52 | Brain-Cortex | Male | WT | Low |
Collection:
Collection ID: | CO003288 |
Collection Summary: | Following euthanasia by terminal anesthesia with isoflurane followed by decapitation, the brains were quickly removed and divided into two hemispheres. One hemisphere was dissected into distinct brain areas including cortex and snap frozen before long term storage at -80 ºC. The second hemisphere was immersion fixed in 4% paraformaldehyde for at least 24 hours before being placed in 30% sucrose for 24-72 hours and then moved to 1xPBS. |
Collection Protocol Filename: | Tissue_acquisition_Cortex.pdf |
Sample Type: | Brain cortex |
Storage Conditions: | -80℃ |
Treatment:
Treatment ID: | TR003304 |
Treatment Summary: | Mice were maintained on standard lab chow (Purina 5001) which contains 70 ppm Mn until 3 months of ages. Mice were then randomly allocated by cage to control (70 ppm; D17020702) or high (2400 ppm) Mn diets. Diets were formulated by Research Diets Inc. and comprised their normal control diet (D19080201) and differed only in the amount of Mn. Food levels were checked at least weekly and mice were weighed monthly to ensure normal growth. |
Treatment Protocol Filename: | Mice_and_dietary_treatment.pdf |
Sample Preparation:
Sampleprep ID: | SP003302 |
Sampleprep Summary: | Cortex tissue samples were analyzed via liquid chromatography-high resolution tandem mass spectrometry (LC-HRMS and LC-HRMS/MS) using previously described methods. Briefly, harvested cortex tissue samples were thawed on ice and lysed in 500 µL ice-cold lysis buffer (1:1:2, acetonitrile: methanol: ammonium bicarbonate 0.1M, pH 8.0) followed by probe tip sonication and normalized via protein amount (100 µg) based on a bicinchoninic acid protein assay (Thermo Fisher Scientific, Waltham, MA). Deproteinization of individual samples was performed by addition of 800 µL of ice-cold methanol following the addition of isotopically labeled standards (phenylalanine-D8, biotin-D2 and lauryl carnitine-D3) to determine sample process variability. Precipitated proteins were centrifuged at 10,000 rpm for 10 min after overnight incubation at -80°C. Metabolite extracts were dried in vacuo and further purified via liquid-liquid extraction (LLE) method with tert-Butyl methyl ether (MTBE). The hydrophilic fraction of each sample extract was transferred into a new Eppendorf tube, dried in vacuo, and stored at -80°C until further use. |
Sampleprep Protocol Filename: | MS_Methods_Cortex.pdf |
Processing Storage Conditions: | -80℃ |
Extract Storage: | -80℃ |
Combined analysis:
Analysis ID | AN005213 | AN005214 |
---|---|---|
Analysis type | MS | MS |
Chromatography type | HILIC | HILIC |
Chromatography system | Thermo Vanquish | Thermo Vanquish |
Column | Waters ACQUITY UPLC BEH Amide (100 x 2.1mm,1.7um) | Waters ACQUITY UPLC BEH Amide (100 x 2.1mm,1.7um) |
MS Type | ESI | ESI |
MS instrument type | Orbitrap | Orbitrap |
MS instrument name | Thermo Q Exactive HF hybrid Orbitrap | Thermo Q Exactive HF hybrid Orbitrap |
Ion Mode | POSITIVE | NEGATIVE |
Units | peak intensity | peak intensity |
Chromatography:
Chromatography ID: | CH003943 |
Chromatography Summary: | Hydrophilic separation |
Methods Filename: | MS_Methods_Cortex.pdf |
Instrument Name: | Thermo Vanquish |
Column Name: | Waters ACQUITY UPLC BEH Amide (100 x 2.1mm,1.7um) |
Column Temperature: | 30 |
Flow Gradient: | 30 min; 95%A, 5%B |
Flow Rate: | 0.20 mL/min |
Solvent A: | 90% water, 10% acetonitrile; 5mM Ammonium Formate, 0.1%FA |
Solvent B: | 10% water, 90% acetonitrile; 5mM Ammonium Formate, 0.1%FA |
Chromatography Type: | HILIC |
MS:
MS ID: | MS004946 |
Analysis ID: | AN005213 |
Instrument Name: | Thermo Q Exactive HF hybrid Orbitrap |
Instrument Type: | Orbitrap |
MS Type: | ESI |
MS Comments: | MS were acquired in both, positive and negative modes Progenesis QI v.3.0 (Non-linear Dynamics, Newcastle, UK) was used to review, process and normalize the mass spectrometry data. The pooled QC sample was used to align all MS and MS/MS sample runs. |
Ion Mode: | POSITIVE |
Analysis Protocol File: | MS_Methods_Cortex.pdf |
MS ID: | MS004947 |
Analysis ID: | AN005214 |
Instrument Name: | Thermo Q Exactive HF hybrid Orbitrap |
Instrument Type: | Orbitrap |
MS Type: | ESI |
MS Comments: | MS were acquired in both, positive and negative modes Progenesis QI v.3.0 (Non-linear Dynamics, Newcastle, UK) was used to review, process and normalize the mass spectrometry data. The pooled QC sample was used to align all MS and MS/MS sample runs. |
Ion Mode: | NEGATIVE |
Analysis Protocol File: | MS_Methods_Cortex.pdf |